Full-Time

Vice President of Lifecycle Marketing

Posted on 9/10/2025

WeightWatchers

WeightWatchers

5,001-10,000 employees

Weight management program with group meetings

Compensation Overview

$250k - $275k/yr

+ Annual Bonus

New York, NY, USA

Hybrid

On-site in NYC 1–2 days per week.

Category
Growth & Marketing (1)
Required Skills
Data Science
Machine Learning
Marketing
Requirements
  • Bachelor's degree in Marketing, Business, Communications, or a related field; MBA or advanced degree preferred.
  • 15+ years in marketing, with a strong focus on CRM, lifecycle, and retention; experience in subscription, health, or digital wellness strongly preferred.
  • Proven track record of improving customer retention and LTV through data-driven, cross-channel lifecycle strategies.
  • Deep experience working with customer data platforms (CDPs), ESPs, and journey orchestration tools.
  • Ability to translate complex data into clear action plans and compelling stories for executive stakeholders.
  • Exceptional leadership, communication, and collaboration skills; proven success managing teams and influencing cross-functional partners.
  • Passion for health, behavior change, and improving people’s lives through actionable marketing and experience design.
Responsibilities
  • Define and execute a holistic lifecycle marketing strategy aligned to business goals and member needs.
  • Own channel strategy and performance across email, push, SMS, in-app messaging, and personalized web content.
  • Develop WW’s behavioral segmentation strategy and apply it across campaigns, product flows, and CRM programs.
  • Build and develop lifecycle focused operating structure team and cross functional focus to exceed performance trends.
  • Champion a test-and-learn culture by driving experimentation and iteration across all lifecycle touchpoints.
  • Serve as the strategic voice for lifecycle across key business initiatives including new service launches, GLP-1 clinical programs, and membership pricing structures.
  • Develop integrated martech infrastructure across systems for reliable, consistent, accurate view of the customer and attributes to improve engagement in our service.
  • Map and optimize key lifecycle moments — from signup to onboarding, activation, habit formation, milestone achievements, renewal, and reactivation.
  • Partner with Product and Engineering to implement in-product marketing and communication flows that reinforce behavioral change and drive stickiness.
  • Identify friction points in the member journey and develop targeted interventions to improve retention and reduce churn.
  • Develop gamification, reward systems and viral growth loops leveraging technical signals from consumer engagement to enrich product experience.
  • Collaborate with Analytics and Data Science to build lifecycle health dashboards, cohort tracking, and predictive churn models.
  • Leverage real-time data signals and event-based triggers to personalize messaging and orchestrate omnichannel experiences.
  • Develop member scoring models and LTV forecasts to inform targeting, offer strategy, and reactivation priorities.
  • Partner with Brand, Creative, and Clinical teams to craft messaging that’s compelling, medically accurate, and aligned to WW’s mission.
  • Work closely with Media and Paid Search to ensure seamless continuity from acquisition to onboarding and early engagement.
  • Integrate CRM strategy into broader marketing and product roadmaps to unify customer experience.
  • Build and mentor a high-performing team of CRM, retention, and lifecycle marketing professionals.
  • Develop career paths, tools, and workflows that scale performance and creativity across the lifecycle function.
  • Manage budgets, timelines, and vendor relationships to deliver operational excellence and measurable outcomes.
Desired Qualifications
  • MBA or advanced degree preferred.
  • Experience in subscription, health, or digital wellness strongly preferred.
  • Experience with customer data platforms, ESPs, and journey orchestration tools is strongly preferred if not already listed as a requirement.

WeightWatchers runs a weight management program centered on group meetings and ongoing support, using a point-based system to guide everyday food choices. Members join, track foods by points, attend meetings for tips and accountability, and can access products and digital tools through its partner ecosystem. Unlike programs that rely only on online plans or single products, WeightWatchers emphasizes emotional support and a broad network of meetings, products, and services tied to a franchise model. Its goal is to help people lose weight and maintain it by building sustainable habits through structure and community.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

New York City, New York

Founded

1963

Simplify Jobs

Simplify's Take

What believers are saying

  • CheqUp expands WW's UK reach into the fast-growing GLP-1 market.
  • Ozempic pill access through Med+ deepens diabetes-member retention and clinical credibility.
  • TANITA scales and tracking tools create higher-margin product attachment opportunities.

What critics are saying

  • FY2026 negative free cash flow of $98 million exposes weak cash conversion.
  • Revenue fell 9.8% in Q1 2026, while analysts expect another 10.6% decline.
  • GLP-1 drugs directly commoditize WW's core subscription model and erode pricing power.

What makes WeightWatchers unique

  • Founded in 1963, WeightWatchers built weight loss around community accountability.
  • WW now pairs behavioral coaching with GLP-1 medications and clinician support.
  • Peoplehood's acquisition adds relationship-building technology for GLP-1 support groups.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at WeightWatchers who can refer or advise you

Benefits

Health Insurance

Flexible Work Hours

Hybrid Work Options

Company News

Yahoo Finance
Mar 24th, 2026
WeightWatchers beats Q4 revenue estimates by 8.7% but shares drop 9.5% on guidance concerns

WeightWatchers reported fourth-quarter revenues of $162.8 million, down 11.7% year-on-year but exceeding analysts' expectations by 8.7%. The company also beat earnings per share and EBITDA estimates. CEO Tara Comonte noted the weight-loss industry is undergoing "profound transformation" driven by GLP-1 medications, with WeightWatchers adapting accordingly. Despite posting the strongest analyst estimate beat amongst 11 consumer discretionary services stocks tracked, the company issued weaker full-year guidance than peers. The sector reported mixed fourth-quarter results overall, with revenues beating consensus estimates by 1.9% whilst next quarter's guidance remained in line. Share prices have struggled following earnings, declining 8.6% on average. WeightWatchers stock has fallen 9.5% since reporting and currently trades at $19.08.

Yahoo Finance
Mar 16th, 2026
WeightWatchers Q4 revenue beats estimates but falls 11.7% to $162.8M

WeightWatchers reported fourth-quarter revenue of $162.8 million, beating analyst estimates by 8.7% but declining 11.7% year on year. The company's GAAP loss of $0.58 per share significantly beat consensus estimates of a $2.03 loss. However, the wellness company's full-year revenue guidance of $627.5 million came in 0.7% below expectations, whilst EBITDA guidance of $110 million for 2026 fell short of analyst estimates of $115.1 million. CEO Tara Comonte acknowledged the industry is undergoing significant transformation driven by GLP-1 medications. WeightWatchers has struggled with demand, with revenue declining at a 12.4% annual rate over the past five years. Analysts expect revenue to decline by 10.8% over the next 12 months.

Yahoo Finance
Feb 27th, 2026
Main Street Capital shines with 64.8% margin while General Mills and WeightWatchers face profit struggles

Main Street Capital, a business development company providing debt and equity capital to middle-market firms, has caught analysts' attention with its strong profitability metrics. The company posted a trailing 12-month GAAP operating margin of 64.8%. Main Street achieved annual revenue growth of 20.5% over the past five years, indicating market share gains. Its 17.6% return on equity demonstrates management's ability to identify high-return investments. Conversely, analysts question General Mills and WeightWatchers. General Mills faces declining unit sales and contracting free cash flow margins despite a 20.5% operating margin. WeightWatchers struggles with underwhelming membership numbers and below-average operating margins at 13%, whilst burning cash. Both companies trade at forward price-to-earnings ratios around 13x.

The Associated Press
Jan 28th, 2026
WeightWatchers and Tanita launch co-branded body composition scales in UK and Ireland

TANITA has partnered with WeightWatchers to launch a co-branded line of body composition and kitchen scales in the UK and Ireland. The collaboration, brokered by Beanstalk, responds to WeightWatchers member feedback requesting more accurate health tracking tools. The "WeightWatchers powered by TANITA" range uses TANITA's patented bioelectrical impedance analysis technology to track metrics including fat mass, muscle mass, visceral fat and metabolic age. Research shows frequent self-weighing with digital tools supports greater weight loss, whilst body composition monitoring helps GLP-1 medication users track muscle mass. The professional-grade scales integrate with the MyTanita App and are available on tanita.co.uk, Amazon.co.uk, and through retailers across the UK and Ireland. TANITA's technology is already trusted by hospitals and fitness professionals globally.

WDC TV News
Aug 7th, 2025
Peoplehood sold to WeightWatchers, pivoted focus

SoulCycle cofounders Julie Rice and Elizabeth Cutler's startup, Peoplehood, has been sold to WeightWatchers. Initially focused on relationship-building, Peoplehood pivoted to support groups for GLP-1 medication users. WeightWatchers, which recently emerged from bankruptcy, acquired Peoplehood's tech and platforms, appointing Rice as chief experience officer. Financial details were undisclosed. Peoplehood had previously raised funding from Maveron.

INACTIVE